NRAS and RASopathy: Altogether, the data in this report strongly support the notion that the combined ablation of HRAS and NRAS leads to increased levels of activated, KRAS-dependent signals that are then responsible for the development of the RASopathy-like phenotypes of DKO mice without the need to acquire any additional, genetic hyperactivating mutations in the signaling pathway.